skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Nebivolol in the treatment of chronic heart failure

(2675) Views  (914) Full article downloads

Authors: Angie Veverka, Jennifer L Salinas

Published Date November 2007 Volume 2007:3(5) Pages 647 - 654
DOI: http://dx.doi.org/10.2147/VHRM.S

Angie Veverka, Jennifer L Salinas

Wingate University School of Pharmacy, Wingate, NC, USA

Abstract: Nebivolol is a highly selective beta1-adrenergic blocker that also enhances nitric oxide bioavailability via the L-arginine-nitric oxide pathway, leading to vasodilation and decreased peripheral vascular resistance. It is marketed in Europe for the treatment of hypertension and heart failure and is currently being reviewed for use in the US by the Food and Drug Administration. Nebivolol appears to be well tolerated with an adverse event profile that is at least similar, if not better, than that of other beta-adrenergic blockers. Studies suggest that long-term therapy with nebivolol improves left ventricular function, exercise capacity, and clinical endpoints of death and cardiovascular hospital admissions in patients with stable heart failure. To date, it is one of the only beta-adrenergic blockers that have been exclusively studied in elderly patients. Additionally, the unique mechanism of action of nebivolol makes it a promising agent for treatment of chronic heart failure in high-risk patient populations, such as African Americans. This article will review the pharmacologic and pharmacokinetic properties of nebivolol as well as clinical studies assessing its efficacy for the treatment of heart failure.

Keywords: nebivolol, beta-adrenergic blockers, heart failure








Readers of this article also read:

Acute coronary syndrome associated with Churg-Strauss syndrome
Emergency endovascular repair of acute descending thoracic aortic dissection
Magnetic resonance imaging in coronary artery bypass surgery – improvement of global and segmental function in patients with severely compromized left ventricular function
Arterial stiffness, hypertension, and rational use of nebivolol
Retinal nerve fiber layer evaluation in multiple sclerosis with spectral domain optical coherence tomography
Retinal nerve fiber layer thickness in recovered and persistent amblyopia
Clinical and economic aspects of the use of nebivolol in the treatment of elderly patients with heart failure
Detection of retinal changes in Parkinson's disease with spectral-domain optical coherence tomography
Editorial
Improvement of adenoviral vector-mediated gene transfer to airway epithelia by folate-modified anionic liposomes
  • Join ISVH

    Be part of the World's leading experts in vascular health by joining the International Society of Vascular Health (ISVH)

  • Testimonials

    "... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University